Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Genmab A/S CPSE:GMAB |
107,53 B | 14,29% | 4/6 | -4,48% | 52,02% | 34,17% | DOWN |
|
ALK-Abelló A/S CPSE:ALK B |
45,07 B | 32,62% | 5/6 | 55,34% | 24,56% | 25,37% | UP |
|
Zealand Pharma A/S CPSE:ZEAL |
19,55 B | 71,10% | 4/6 | -51,93% | 89,66% | 80,57% | DOWN |
|
Bavarian Nordic A/S CPSE:BAVA |
15,00 B | 21,29% | 5/6 | -21,10% | 16,95% | 41,53% | DOWN |
|
BioPorto A/S CPSE:BIOPOR |
0,42 B | -11,13% | 2/4 | 0,00% | 15,31% | -100,00% | DOWN |
|
FluoGuide A/S OM:FLUO |
0,63 B | 0,00% | 2/4 | 0,00% | 0,00% | 93,40% | DOWN |
|
Evaxion A/S NasdaqCM:EVAX |
0,03 B | 0,00% | 0/0 | -47,94% | -154,29% | 163,16% | DOWN |
|
Initiator Pharma A/S OM:INIT |
0,21 B | 0,00% | 2/4 | 0,00% | 0,00% | 209,09% | DOWN |
|
Strategic Partners A/S CPSE:STRAP |
0,03 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
IO Biotech NasdaqGS:IOBT |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | 21700,00% | DOWN |
|
Scandion Oncology A/S BST:8VY |
0,00 B | 0,00% | 3/4 | 0,00% | 0,00% | 0,00% | DOWN |
|
Forward Pharma A/S OTCPK:FWPA.Y |
0,00 B | 0,00% | 0/0 | 0,00% | 0,00% | -100,00% | DOWN |
